Published in Eur J Cardiovasc Prev Rehabil on February 01, 2006
The association between blood pressure and incident Alzheimer disease: a systematic review and meta-analysis. Epidemiology (2011) 2.01
Worldwide epidemic of hypertension. Can J Cardiol (2006) 1.55
Age- and gender-specific awareness, treatment, and control of cardiovascular risk factors and subclinical vascular lesions in a founder population: the SardiNIA Study. Nutr Metab Cardiovasc Dis (2009) 1.08
Trends in prevalence, awareness, treatment, and control of hypertension, and the risk of mortality among middle-aged Lithuanian urban population in 1983-2009. BMC Cardiovasc Disord (2012) 1.05
Prevalence, awareness, treatment, and control of hypertension: rule of thirds in the Skaraborg project. Scand J Prim Health Care (2012) 0.99
Trends of blood pressure levels and management in Västerbotten County, Sweden, during 1990-2010. Glob Health Action (2012) 0.90
Physicians' perceptions and adherence to guidelines for the management of hypertension: a national, multicentre, prospective study. Int J Hypertens (2012) 0.85
The antihypertensive effect of ethyl acetate extract from red raspberry fruit in hypertensive rats. Pharmacogn Mag (2011) 0.85
Assessing the impact of medication use on trends in major coronary risk factors in older British men: a cohort study. Eur J Cardiovasc Prev Rehabil (2010) 0.84
Tendency for age-specific mortality with hypertension in the European Union from 1980 to 2011. Int J Clin Exp Med (2015) 0.82
Long term trends in control of hypertension in the Northern Sweden MONICA study 1986-2009. BMC Public Health (2015) 0.80
Role of valsartan, amlodipine and hydrochlorothiazide fixed combination in blood pressure control: an update. Vasc Health Risk Manag (2010) 0.75
Factors associated with awareness, treatment and control of hypertension in a disadvantaged rural Indian population. J Hum Hypertens (2017) 0.75
Six-year changes in the prevalence of obesity and obesity-related diseases in Northeastern China from 2007 to 2013. Sci Rep (2017) 0.75
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J (2003) 8.51
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet (2012) 4.63
Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S). Lancet (2004) 3.59
European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2003) 3.43
Central sympatholytic therapy has anti-inflammatory properties in hypertensive postmenopausal women. J Hypertens (2008) 2.10
Trends in obesity and energy supply in the WHO MONICA Project. Int J Obes Relat Metab Disord (2004) 2.07
Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up. J Hypertens (2007) 1.96
Are changes in mortality from stroke caused by changes in stroke event rates or case fatality? Results from the WHO MONICA Project. Stroke (2003) 1.93
Dynamics of cardiovascular and all-cause mortality in Western and Eastern Europe between 1970 and 2000. Eur Heart J (2005) 1.91
Cold periods and coronary events: an analysis of populations worldwide. J Epidemiol Community Health (2005) 1.89
Bundle-branch block in middle-aged men: risk of complications and death over 28 years. The Primary Prevention Study in Göteborg, Sweden. Eur Heart J (2005) 1.83
Body mass index, other cardiovascular risk factors, and hospitalization for dementia. Arch Intern Med (2005) 1.81
Psychosocial considerations in the European guidelines for prevention of cardiovascular diseases in clinical practice: Third Joint Task Force. Int J Behav Med (2005) 1.74
Trends in cigarette smoking in 36 populations from the early 1980s to the mid-1990s: findings from the WHO MONICA Project. Am J Public Health (2001) 1.69
Trends in coronary risk factors in the WHO MONICA project. Int J Epidemiol (2001) 1.61
The association between blood pressure, hypertension, and cerebral white matter lesions: cardiovascular determinants of dementia study. Hypertension (2004) 1.59
Impact of age on the importance of systolic and diastolic blood pressures for stroke risk: the MOnica, Risk, Genetics, Archiving, and Monograph (MORGAM) Project. Hypertension (2012) 1.54
Trends in stroke and coronary heart disease in the WHO MONICA Project. Stroke (2003) 1.49
Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study. Horm Res (2003) 1.47
The effect of temperature on systolic blood pressure. Blood Press Monit (2007) 1.46
Trends in hypertension care in eastern and south-western Finland during 1982-2002. J Hypertens (2006) 1.46
Prevention of coronary heart disease by diet and lifestyle: evidence from prospective cross-cultural, cohort, and intervention studies. Circulation (2002) 1.43
Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men. Eur Heart J (2009) 1.41
Do other cardiovascular risk factors influence the impact of age on the association between blood pressure and mortality? The MORGAM Project. J Hypertens (2014) 1.41
Long-term risk factors for stroke: twenty-eight years of follow-up of 7457 middle-aged men in Göteborg, Sweden. Stroke (2006) 1.40
European guidelines on cardiovascular disease and prevention in clinical practice. Atherosclerosis (2003) 1.31
Effect on trend estimates of the difference between survey respondents and non-respondents: results from 27 populations in the WHO MONICA Project. Eur J Epidemiol (2005) 1.30
Re-evaluating the Rose approach: comparative benefits of the population and high-risk preventive strategies. Eur J Cardiovasc Prev Rehabil (2009) 1.28
How much does HDL cholesterol add to risk estimation? A report from the SCORE Investigators. Eur J Cardiovasc Prev Rehabil (2009) 1.28
Body mass index in mid-life is associated with a first stroke in men: a prospective population study over 28 years. Stroke (2004) 1.23
Analysis of the relationship between total cholesterol, age, body mass index among males and females in the WHO MONICA Project. Int J Obes Relat Metab Disord (2004) 1.20
Prevalence, awareness and treatment of hypercholesterolaemia in 32 populations: results from the WHO MONICA Project. Int J Epidemiol (2005) 1.18
Geriatric drug therapy and healthcare utilization in the United kingdom. Ann Pharmacother (2002) 1.15
Trends in blood lipid levels, blood pressure, alcohol and smoking habits from 1985 to 2002: results from INTERGENE and GOT-MONICA. Eur J Cardiovasc Prev Rehabil (2005) 1.09
Overweight and obesity in patients with established coronary heart disease: are we meeting the challenge? Eur Heart J (2004) 1.05
Current smoking and the risk of non-fatal myocardial infarction in the WHO MONICA Project populations. Tob Control (2004) 1.04
The data monitoring experience in the MOXCON trial. Eur Heart J (2004) 1.03
Cerebral changes on MRI and cognitive function: the CASCADE study. Neurobiol Aging (2006) 1.01
Cancer incidence, mortality from cancer and survival in men of different occupational classes. Eur J Epidemiol (2004) 1.01
Coronary disease in relation to social support and social class in Swedish men. A 15 year follow-up in the study of men born in 1933. Eur Heart J (2004) 1.01
Effects of self-rated health on sick leave, disability pension, hospital admissions and mortality. A population-based longitudinal study of nearly 15,000 observations among Swedish women and men. BMC Public Health (2012) 1.01
Population-level changes to promote cardiovascular health. Eur J Prev Cardiol (2012) 1.00
Non-pharmacological treatment of hypertension in primary health care: a 2-year open randomized controlled trial of lifestyle intervention against hypertension in eastern Finland. J Hypertens (2002) 0.99
Relationships between body mass index, cardiovascular mortality, and risk factors: a report from the SCORE investigators. Eur J Cardiovasc Prev Rehabil (2011) 0.98
Stroke incidence and mortality rates 1987 to 2006 related to secular trends of cardiovascular risk factors in Gothenburg, Sweden. Stroke (2009) 0.97
Prevalence of cardiovascular risk factors and the metabolic syndrome in middle-aged men and women in Gothenburg, Sweden. BMC Public Health (2008) 0.95
High lipid levels and coronary disease in women in Göteborg--outcome and secular trends: a prospective 19 year follow-up in the BEDA*study. Eur Heart J (2003) 0.94
Secular trends in sex hormones and fractures in men and women. Eur J Endocrinol (2012) 0.93
Hypothyroidism is common in turner syndrome: results of a five-year follow-up. J Clin Endocrinol Metab (2004) 0.93
Screening for people with glucose metabolism disorders within the framework of the DEMOJUAN project (DEMOnstration area for primary prevention of type 2 diabetes, JUAN Mina and Barranquilla, Colombia). Diabetes Metab Res Rev (2013) 0.93
Use of oral contraceptives and hormone replacement therapy in the WHO MONICA project. Maturitas (2004) 0.92
Chromosomal mosaicism mitigates stigmata and cardiovascular risk factors in Turner syndrome. Clin Endocrinol (Oxf) (2007) 0.91
[European Guidelines on Cardiovascular Disease Prevention in Clinical Practice: CEIPC 2008 Spanish adaptation]. Rev Esp Salud Publica (2009) 0.91
[Spanish adaptation of the European Guidelines on Cardiovascular Disease Prevention]. Rev Esp Salud Publica (2004) 0.90
Job stress and major coronary events: results from the Job Stress, Absenteeism and Coronary Heart Disease in Europe study. Eur J Cardiovasc Prev Rehabil (2006) 0.89
Insulin-like growth factor I levels in healthy adults. Horm Res (2004) 0.89
Risk stratification in cardiovascular disease primary prevention - scoring systems, novel markers, and imaging techniques. Fundam Clin Pharmacol (2012) 0.87
Aspirin increases mortality in diabetic patients without cardiovascular disease: a Swedish record linkage study. Pharmacoepidemiol Drug Saf (2009) 0.87
Prevalence and determinants of obesity in children in public schools of Sintra, Portugal. Obesity (Silver Spring) (2008) 0.87
Prevention of cardiovascular disease guided by total risk estimations--challenges and opportunities for practical implementation: highlights of a CardioVascular Clinical Trialists (CVCT) Workshop of the ESC Working Group on CardioVascular Pharmacology and Drug Therapy. Eur J Prev Cardiol (2012) 0.85
Stroke and coronary heart disease: predictive power of standard risk factors into old age--long-term cumulative risk study among men in Gothenburg, Sweden. Eur Heart J (2013) 0.84
Blood pressure is insufficiently controlled in European patients with established coronary heart disease. J Hypertens (2003) 0.84
Body mass index, coronary heart disease and stroke in Swedish women. A prospective 19-year follow-up in the BEDA study. Eur J Cardiovasc Prev Rehabil (2003) 0.83
The relation of body mass index and abdominal adiposity with dyslipidemia in 27 general populations of the WHO MONICA Project. Nutr Metab Cardiovasc Dis (2011) 0.83
Predictors of coronary bypass grafting in a population of middle-aged men. Eur J Cardiovasc Prev Rehabil (2007) 0.83
Occupational status and incidences of ischemic and hemorrhagic stroke in Swedish men: a population-based 35-year prospective follow-up study. Eur J Epidemiol (2013) 0.83
Is the increase in coronary events on Mondays an artifact? Epidemiology (2004) 0.82
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force Of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Arch Mal Coeur Vaiss (2004) 0.82
High-normal blood pressure and long-term risk of type 2 diabetes: 35-year prospective population based cohort study of men. BMC Cardiovasc Disord (2012) 0.82
Standardization of total cholesterol measurement in population surveys--pre-analytic sources of variation and their effect on the prevalence of hypercholesterolaemia. Eur J Cardiovasc Prev Rehabil (2005) 0.81
Residual risk of cardiovascular mortality in patients with coronary heart disease: the EUROASPIRE risk categories. Int J Cardiol (2012) 0.81
Association between ghrelin gene variations and blood pressure in subjects with impaired glucose tolerance. Am J Hypertens (2006) 0.81
Optimising health care within given budgets: primary prevention of cardiovascular disease in different regions of Sweden. Health Policy (2006) 0.81
Interobserver and intraobserver variability of the apparent diffusion coefficient in treated malignant hepatic lesions on a 3.0T machine: measurements in the whole lesion versus in the area with the most restricted diffusion. J Magn Reson Imaging (2010) 0.81
Changes in gene expression profile in human subcutaneous adipose tissue during significant weight loss. Obes Facts (2012) 0.80
Effect of sampling frames on response rates in the WHO MONICA risk factor surveys. Eur J Epidemiol (2005) 0.80
Blood pressure treatment target in patients with diabetes mellitus--current evidence. Ann Med (2012) 0.79
Population-based register of acute myocardial infarction: manual of operations. Eur J Cardiovasc Prev Rehabil (2007) 0.79
Implementation of Spanish adaptation of the European guidelines on cardiovascular disease prevention in primary care. BMC Fam Pract (2013) 0.77
[European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. CEIPC 2008 Spanish Adaptation]. Aten Primaria (2009) 0.77
Stroke risk estimation across nine European countries in the MORGAM project. Heart (2010) 0.77
Perceived health in 50-year-old women and men and the correlation with risk factors, diseases, and symptoms. Gend Med (2011) 0.77
In search of the grail: the never-ending story of biomarkers for coronary risk prediction. Eur Heart J (2004) 0.77
The data monitoring experience in the Candesartan in Heart Failure Assessment of Reduction in Mortality and morbidity (CHARM) program. Am Heart J (2005) 0.76
Correction: Impact of Age and Gender on the Prevalence and Prognostic Importance of the Metabolic Syndrome and Its Components in Europeans. The MORGAM Prospective Cohort Project. PLoS One (2015) 0.76
Chronic diseases and call to action. Int J Epidemiol (2010) 0.75
[Quitting smoking and social equity]. Rev Esp Cardiol (2002) 0.75
[In memoriam. Ignasi Balaguer-Vintró (25/5/1925-20/3/2014)]. Gac Sanit (2014) 0.75
[Statement of the Spanish Interdisciplinary Cardiovascular Prevention Committee (CEIPC) on the 2012 European Cardiovascular Prevention Guidelines]. Rev Esp Salud Publica (2013) 0.75
[Fewer side effects and lower mortality from modern antipsychotic drugs. But they are more expensive than older antipsychotics, based on a study from Västra Götaland]. Lakartidningen (2012) 0.75
[Statement of the Spanish Interdisciplinary Cardiovascular Prevention Committee (CEIPC for its Spanish acronym) on the 2012 European Cardiovascular Prevention Guidelines]. Clin Investig Arterioscler (2013) 0.75
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S). 1998. Atheroscler Suppl (2004) 0.75